Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 2 patents
18 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119164

Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.

E Elstner, M Linker-Israeli, J Le, T Umiel, P Michl, J W Said, L Binderup, J C Reed, and H P Koeffler

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Elstner, E. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Linker-Israeli, M. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Le, J. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Umiel, T. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Michl, P. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Said, J. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Binderup, L. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Reed, J. in: PubMed | Google Scholar

Division of Hematology-Oncology, University of California, Los Angeles School of Medicine, 90048, USA.

Find articles by Koeffler, H. in: PubMed | Google Scholar

Published January 15, 1997 - More info

Published in Volume 99, Issue 2 on January 15, 1997
J Clin Invest. 1997;99(2):349–360. https://doi.org/10.1172/JCI119164.
© 1997 The American Society for Clinical Investigation
Published January 15, 1997 - Version history
View PDF
Abstract

Patients with acute promyelocytic leukemia (APL) usually relapse after all-trans retinoic acid (RA) treatment because this therapy fails to eradicate the malignant clone. Our data showed that KH 1060 and other 20-epi vitamin D3 analogs alone were potent inhibitors of clonal growth of NB4 cells, an APL cell line (ED50, approximately 5 x 10(-11) M). The combination of KH 1060 and 9-cis-RA synergistically and irreversibly enhanced this effect. Neither KH 1060 nor 9-cis-RA (10(-6) M, 3 d) were strong inducers of differentiation of NB4 cells. However, 98% of the cells underwent differentiation to a mature phenotype with features of both granulocytes and monocytes after exposure to a combination of both compounds. Apoptosis only increased after incubation of NB4 cells with 9-cis-RA alone (28%) or with a combination of 9-cis-RA plus KH1060 (32%). Immunohistochemistry showed that the bcl-2 protein decreased from nearly 100% of the wild-type NB4 cells to 2% after incubation with a combination of KH 1060 and 9-cis-RA, and the bax protein increased from 50% of wild-type NB4 cells to 92% after culture with both analogs (5 x 10(-7) M, 3 d). Western blot analysis paralleled these results. Studies of APL cells from one untreated individual paralleled our results with NB4 cells. Taken together, the data demonstrated that nearly all of the NB4 cells can be irreversibly induced to differentiate terminally when exposed to the combination of KH 1060 and 9-cis-RA.

Version history
  • Version 1 (January 15, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
18 readers on Mendeley
See more details